* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download West Nile Virus
Cross-species transmission wikipedia , lookup
Herpes simplex wikipedia , lookup
Neonatal infection wikipedia , lookup
Swine influenza wikipedia , lookup
Sarcocystis wikipedia , lookup
Yellow fever wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Hepatitis C wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
2015–16 Zika virus epidemic wikipedia , lookup
Ebola virus disease wikipedia , lookup
Influenza A virus wikipedia , lookup
Antiviral drug wikipedia , lookup
Hepatitis B wikipedia , lookup
Orthohantavirus wikipedia , lookup
Herpes simplex virus wikipedia , lookup
Marburg virus disease wikipedia , lookup
Lymphocytic choriomeningitis wikipedia , lookup
State Research Center of Virology and Biotechnology “VECTOR” Institute of Molecular Biology Department of Molecular Virology INTERNATIONAL COLLABORATION IN STUDY OF THE FLAVIVIRUSES V.B. Loktev Lescar et al, Cell, 2001 Family: Flaviviridae Genus: Prototype virus Flavivirus Yellow fever virus Flavivirus genus contains approximately 72 viruses Pestivirus Bovine diarrhea virus Hepacivirus Hepatitis C virus Groups of the flavivirus • yellow fever virus group • tick-borne encephalitis virus mosquito-borne, 1 species tick-borne, 16 species • • no known vector, 6 species mosquito-borne, 10 species • • • • • • group Rio Bravo virus group Japanese encephalitis virus group Tyuleniy virus group Ntaya virus group Uganda S virus group Dengue virus group Modoc virus group Tentative Species in the Genus – tick-borne viruses – mosquito-borne viruses – viruses with no known vector tick-borne, 3 species mosquito-borne, 5 species mosquito-borne, 4 species mosquito-borne, 4 species no known vector, 5 species 2 species 11 species 5 species ICTV-2002 Flavivirus Genome • • • • • ss (+) RNA genome Approximately 11 kb 5’-m7GpppAmp cap Lacks 3’-polyA tail Codes for – 3 structural proteins • Capsid (C), membrane (prM/M), envelope (E) – 7 non-structural proteins • NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5 Lescar et al, Cell, 2001 Envelope proteins of intracellular and extracellular flavivirus virions. E-protein • Approximately 54 kDa • Dimer positioned parallel to virus surface • Three domains I - Central domain II - Dimerization domain III - Immunogenic/Receptor binding domain Volk et al, 2004 Volk et al, 2004 Non-structural proteins NS1 46 kDa Main antigen, modified of cell membrane Possibly participation in RNA replication 14 and 22 NS2a and NS2b kDa Function unknown Replicase? NS2b – co-factor for protease NS3 Several enzyme activities Protease, helicase NS4a and 16 and 27 kDa NS4b Membraneassociated proteins Modification of cell membranes NS5 Polymerase RNA polimerase and methyltransherase activity 70 kDa 103 kDa Major Flavivirus Diseases • Dengue • Japanese encephalitis • Tick-borne encephalitis • West Nile • Yellow fever Current Flavivirus Vaccines Live attenuated/weakened • Yellow fever • Japanese encephalitis Inactivated/killed • Japanese encephalitis • Tick-borne encephalitis No vaccines • Dengue • West Nile Sohn YM, Emerg Infect Dis. 2000 Jan-Feb;6(1):17-24. West Nile Virus • First isolated in 1937 in Uganda. • First recorded epidemic in Israel in 1950’s. • Found in Africa, Europe and Asia. • Introduced into Western hemisphere during 1999 in New York. Family: Flaviviridae Genus: Flavivirus Japanese encephalitis virus group • Alfuy virus • Japanese encephalitis virus • Kokobera virus • Koutango virus • Kunjin virus • Murray Valley encephalitis virus • St. Louis encephalitis virus • Stratford virus • Usutu virus • West Nile virus ICTV-2002 West Nile Virus Transmission Cycle Mosquito vector Incidental infections Incidental infections Bird reservoir hosts Animal hosts: • Bird • Horse • Human • Hamster • Mouse ВЗН обнаружен в более чем в 115 различных видах организмов !!! Pathogenesis • Virus infects host via • • • mosquito bite. Multiplication in tissues and lymph nodes near site of entry. Virus moves to blood via lymphatics; viremia detected early in infection. Infection of central nervous system takes place. Solomon et al, BMJ, 2003 Outbreak of WNV infection Solomon et al, BMJ, 2003 States with West Nile virus and those with increased risk of acquiring the virus, November 1999 States at risk from West Nile virus States with West Nile virus Gubler et al. 2002 States with West Nile virus and those with increased risk of acquiring the virus, November 2000 States at risk from West Nile virus States with West Nile virus Gubler et al. 2002 States with West Nile virus and those with increased risk of acquiring the virus, November 2001 States at risk from West Nile virus States with West Nile virus Gubler et al. 2002 States with West Nile virus, September 2002 States with West Nile virus Gubler et al. 2002 West Nile virus in 2002 Solomon et al, BMJ, 2003 West Nile in the United States States of Cases of Deaths USA WN infection Mortality rate % 1999 1 62 7 11,3 2000 3 21 2 9,5 2001 10 66 9 13,6 2002 42 4156 286 6,9 2003 45 9006 220 2,44 USA – 2004, on 31 August – 1053 human cases (28 fatal) • California – 326, Arizona – 316, Colorodo – 141 – 85 positive donors – 3978 positive birds (dead) in 44 states – 4024 positive mosquito pools in 31 states • Canada – 15 human cases – 325 positive birds www.promedmail.org Campbell et all, Lancet, 2002 Phylogenetic tree of West Nile viruses Lanciotti, et al // Virology.2002. V. 298, P. 96-105. New moments in epidemiology of the WN infection • Blood transfusion (737 donors on 25.11.2003) • Organs transplantation • Breast-feeding • Stem cells transplantation • Laboratory incidents • Transplacental pathway Number of publications on WNV infection (Medline data) 400 350 Publication 300 250 200 150 100 50 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 Incidence of reported cases of dengue hemorrhagic fever, worldwide, 1968 to 1998, and showing a dramatic increase in incidence in the recent past. Distribution of dengue hemorrhagic fever in the Americas before 1981 and during the period from 1981 to 1998, showing spread of the disease as a result of reinvasion of the region by the Aedes aegypti vector and the introduction and transmission of multiple dengue serotypes. West Nile in the Russia, outbreak of WN infection in 1999 380 confirmed cases including 38 fatalities Volgograd Astrakhan 95 confirmed cases including 5 fatalities 2000 1999 1998 1997 1996 1995 1993 1992 1991 100 90 80 70 60 50 40 30 20 10 0 1967 Cases West Nile in Astrakhan Region Butenko et al 2000 West Nile virus in the Russia in 2002 West Nile virus in 2003 2300 km 4000 km Phylogenetic tree of Siberian variants of WN viruses 2002, Western Siberia Human case in Novosibirsk • Latent time – 14 days? • Clinical picture – 10 days fever • Vaccination – Complete course of immunization against TBE virus • • • • Titer against TBE virus (IgG) – 1:400 (constant) Titer against WNV (IgG) – up to 1:3200 RT PCR – positive Sequence of cDNA fragment (gene E protein) – genotype I of WNV, Volgograd like. • Additional – PCR positive on Lyme disease, mixed infection?! (Morozova et a, 2004, personal report) Conclusion on WN infection in the Russia • Outbreak of the WN infection in Russia were • • • recorded in 1999. The Volgograd isolates had the greatest homology (99.6%) with WN-Romania1996 mosquito strain RO97-50; WNV was found in birds which were collected in the south of Western Siberia in the summerautumn of 2002-2003; Siberian variants of WNV showed the maximum level of homology with the strain WNV/LEIVVlg99-27889 isolated in Volgograd in 1999. The high level of homology between these sequences suggests a connection between WNV circulating in Northern Caspian region and Western Siberia. 7 6 5 4 3 2 2003 2002 2001 2000 1999 1998 1997 1996 1995 1990 1985 1980 1975 1970 1965 1960 1955 1950 1945 0 1940 1 Number of cases (per/100.000) of TBE infection in the Russia (USSR) during 1940-2001. TBE infection in Austria and Czech Rep. New Variants of Tick-Borne Encephalitis Virus Discovered by Retrospective Investigation of Fatal Cases of Tick-Borne Encephalitis with Hemorrhagic Syndrome Occurred in Novosibirsk Region (Russia) During Summer of 1999 Background: In 1999, 447 TBE cases confirmed by enzyme immunoassay were reported in Novosibirsk region. The mortality rate was 2.0%. The fatal outcomes of eight patients were associated with development of a pronounced hemorrhagic syndrome. Archival samples of formalin-fixed brain tissue from the fatal cases were collected only in March 2000. Previously they were stored for 89 months in 10% formaldehyde solution at room temperature Distribution of hemorrhagic TBE cases in Novosibirsk region in summer of 1999. Main clinical dates for hemorrhagic TBE Age of patients: Latent period 44 - 69 years 12,8 days First fever symptoms 0 day First hemorrhagic symptom 7 day CNS manifestation Massive hemorrhagic manifestation Dead 10 day 13-14 day 16 day Homology (%) between the nucleotide acid sequences of prototype strains for various subtypes of TBEV and OHF virus Subtypes neud sofjin botsad koltsovo1 koltsovo19 koltsovo23 koltsovo29 omskhf 1 European neud 100.00 81.94 84.72 81.67 80.28 78.61 80.83 80.28 2 Far Eastern 3 Siberian sofjin 81.94 100.00 85.28 99.72 92.50 91.39 92.78 77.78 botsad 84.72 85.28 100.00 85.00 83.33 82.50 83.61 78.89 omskhf 80.28 77.78 78.89 78.06 76.67 75.00 77.50 100.00 Phylogenetic tree for nucleotide sequences of protein E of TBEV Subtype 3 (Siberian subtype) Subtype 1 (European subtype) Subtype 2 (Far Eastern subtype Far Eastern Subtype of TBEV 1937 Sofiin 1953 1993 Oshima 1979 1977 1987, Crimea 1939 1999, Koltsovo 1937 Sofiin 1993 Oshima 1953 1979 Conclusion on hemorrhagic TBEV: Analysis of nucleotide sequences of these fragments showed that homology with subtype 3 (Siberian subtype) of TBEV was approximately 82%. The new variants cluster together with subtype 2 (Far Eastern subtype) of TBEV (homology, 94.7%) in phylogenetic analysis. Thirteen new amino acid mutations in domain II of protein E were mapped. We conclude that new and unusual variants of TBEV have recently emerged in Novosibirsk region. These variants appear to be capable of inducing a hemorrhagic syndrome in the infected humans. Summary: • Emerging of new variants of flaviviruses is new threat for the human and public health. • Modern variants of flaviviruses are distributed in most countries of world. • The flaviviruses is hot problem of modern virology. • SRC VB «Vector» – – – – – – – V.A. Ternovoi A.M. Shestopalov E.V. Protopopova S.I. Zolotykh Yu.V.Kononova S.V. Netesov V.B. Loktev • Novosibirsk State Medical Academy – G.P. Kurzhukov • 1st Municipal Clinical Infectious Hospital of Novosibirsk – G.Y. Ivanov – Y.V. Sokolov • D.I. Ivanovsky Institute of Virology, Russian Academy of Medical Sciences, Moscow – M.Yu. Shchelkanov – V.A. Aristova – V.L. Gromashevsky, – D.K. L’vov • University of North Carolina, USA – R.W. Ryder • Stanford University, USA – A.V. Loktev • Institute of Systematic and Ecology of Animal, SB RAS, Novosibirsk – A.V. Druzyaka • Institute of Epidemiology and Microbiology, SB RAMS, Irkutsk – M.A. Khasnatinov • National Center for Infectious Diseases, Ulan-Bator, Mongolia – D.Abmid • National Center for Natural Foci Infectious Diseases, Ulan-Bator, Mongolia – D.Tserennorov – D.Batjav – D.Otgonbaatar • JSC “Vector-Best”, Novosibirsk – M.P. Grishaev • Research Institute of Epidemiology and Microbiology, SB RAMS, Vladivostok – G.N. Leonova • Khasan Natural Park, Primorye Region – E.V. Radiulov Many thanks for your attention !